Skip to content
MS
PW-039 Lipid Metabolism Anabolic (signalling) unreviewed

Eicosanoid Synthesis

Arachidonic acid (from membrane phospholipid) Prostaglandins, thromboxanes, prostacyclin, leukotrienes
Compartment
Cytosol / ER / nuclear membrane
Main tissue
Platelets, endothelium, leukocytes, most tissues
Rate-limiting
Phospholipase A2; Cyclooxygenase (COX-1 / COX-2; PTGS1/2)
Steps
5

Reaction steps

In source order, 5 total

showing 1–5
  1. 1

    Membrane phospholipid -> arachidonic acid + lysophospholipid

    Phospholipase A2 3.1.1.4 ST-0315 Irreversible/directional rate-limiting Ca2+
    › Notes

    Rate-limiting release of the 20:4 omega-6 precursor. Corticosteroids suppress this step.

  2. 2

    Arachidonic acid + 2 O2 -> PGG2 -> PGH2

    › Notes

    Bifunctional cyclooxygenase + peroxidase. Irreversibly acetylated by aspirin; reversibly inhibited by other NSAIDs; COX-2 selectively inhibited by coxibs.

  3. 3

    PGH2 -> PGE2 / PGD2 / PGF2alpha / PGI2 / TXA2

    › Notes

    Endothelium favours PGI2 (vasodilator, antiaggregatory); platelets favour TXA2 (vasoconstrictor, proaggregatory) - the basis of low-dose aspirin cardioprotection.

  4. 4

    Arachidonic acid + O2 -> 5-HPETE -> LTA4

    5-Lipoxygenase (ALOX5) + FLAP 1.13.11.34 ST-0318 Irreversible/directional O2 Fe
    › Notes

    Branch point of the leukotriene arm; zileuton inhibits 5-LOX.

  5. 5

    LTA4 -> LTB4, or LTA4 + glutathione -> LTC4 -> LTD4 -> LTE4

    › Notes

    LTB4 is a neutrophil chemoattractant; the cysteinyl leukotrienes are the slow-reacting substance of anaphylaxis and are blocked at the receptor by montelukast/zafirlukast.

Showing all 5 steps.

Recent literature

Live Europe PMC search

Europe PMC · fetched just now · sorted by publication date

  1. 1
    Inflammation and carcinogenesis: molecular targets and small-molecule intervention strategies.

    Lu WJ, Ojha R, Rana M, Gautam V, Li JY, Wang SA. · 2026-06-26

    open access unreviewed
  2. 2
    Gut microbiota in chronic inflammation: the interplay with lipid mediators.

    Bao S, Yao C. · 2026-05-06

    open access unreviewed
  3. 3
    Nuciferine Suppresses Inflammatory Hepatocarcinogenesis by Targeting cPLA2‐Dependent Arachidonic Acid Metabolism

    Sun J, Wu X, Luo S, Liu Y, Liu J, Lu J, Wang W, Feng X, Zhang T, Panigrahy D, Deng J, Liao X, Yang H. · 2026-10-08

    open access unreviewed
  4. 4
    PGE2 Enhances Human ILC3 Function but Constrains ILC2‐to‐ILC3 Plasticity

    Wirth L, Weigel W, Kokkinou E, Kolmert J, Johnsson A, Quaranta A, Wheelock C, Jangard M, Pandey R, Dahlén S, … · 2026-10-01

    open access unreviewed
  5. 5
    Synergistic Phytochemicals From Mitracarpus frigidus (Willd. ex Roem. & Schult.) K. Schum. and Lantana camara Linn. in Chitosan Biofilms: Antioxidant and Anti-Inflammatory Activities With Wound-Healing Potential.

    Mayrink NS, Fajardo JB, Comitre MRC, Carvalho LA, Dalcol MI, Paula PL, Campos LM, Guedes MCMR, Cappa de Olive… · 2026-10-01

    open access unreviewed
  6. 6
  7. 7
  8. 8
    Systemic Inflammatory Response During Coronary Artery Bypass Grafting with Cardiopulmonary Bypass: Cellular and Molecular Mechanisms.

    Lazović DM, Cvetković D, Kočica MK, Ivanišević D, Aleksić V, Kočica MJ, Grujić D, Nešić S, Klać J, Grujić M, … · 2026-09-21

    open access unreviewed
  9. 9
    Developments in Mast Cell Research.

    Piliponsky AM, Hallstrand TS. · 2026-09-21

    unreviewed
  10. 10
    Fatty Acid Composition of Fixed Oil of Linum strictum and Its Antibiofilm, Anticoagulant, and α-Amylase Inhibitory Effects-In Vitro and In Silico Study.

    Edziri H, Bargali P, Melliti M, Aljohi H, NasserAlkhrayef M, Gtari R, Iriti M, Kumar R, Alanazi IO. · 2026-09-01

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.